Page last updated: 2024-10-26

eperisone and Acute Pain

eperisone has been researched along with Acute Pain in 1 studies

eperisone : A racemate that is an equimolar mixture of (R)- and (S)-eperisone. It is used (as the hydrochloride salt) as a muscle relaxant for the symptomatic treatment of muscle spasm and spasticity.
1-(4-ethylphenyl)-2-methyl-3-(piperidin-1-yl)propan-1-one : An aromatic ketone that is N-propylpiperidine in which a hydrogen at positon 2 of the propyl group is replaced by a p-ethylbenzoyl group.

Acute Pain: Intensely discomforting, distressful, or agonizing sensation associated with trauma or disease, with well-defined location, character, and timing.

Research Excerpts

ExcerptRelevanceReference
" Aceclofenac and eperisone hydrochloride are commonly prescribed drugs for acute LBP and muscle spasms."9.69Evaluation of the efficacy and safety of NVP-1203 and aceclofenac in patients with acute low back pain and muscle spasm: A randomized, double-blind, active-controlled, parallel, multicenter, phase 3 clinical trial. ( Cho, JH; Kang, CN; Kim, HJ; Kim, JH; Kim, SH; Kim, TK; Lee, JH; Lee, S; Moon, SH, 2023)
" Aceclofenac and eperisone hydrochloride are commonly prescribed drugs for acute LBP and muscle spasms."5.69Evaluation of the efficacy and safety of NVP-1203 and aceclofenac in patients with acute low back pain and muscle spasm: A randomized, double-blind, active-controlled, parallel, multicenter, phase 3 clinical trial. ( Cho, JH; Kang, CN; Kim, HJ; Kim, JH; Kim, SH; Kim, TK; Lee, JH; Lee, S; Moon, SH, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lee, S1
Kim, HJ1
Kim, JH1
Kim, TK1
Kang, CN1
Lee, JH1
Cho, JH1
Kim, SH1
Moon, SH1

Trials

1 trial available for eperisone and Acute Pain

ArticleYear
Evaluation of the efficacy and safety of NVP-1203 and aceclofenac in patients with acute low back pain and muscle spasm: A randomized, double-blind, active-controlled, parallel, multicenter, phase 3 clinical trial.
    European review for medical and pharmacological sciences, 2023, Volume: 27, Issue:1

    Topics: Acute Pain; Double-Blind Method; Humans; Low Back Pain; Pain Measurement; Spasm; Treatment Outcome

2023